nodes	percent_of_prediction	percent_of_DWPC	metapath
Diltiazem—hypertension—focal segmental glomerulosclerosis	0.678	1	CtDrD
Diltiazem—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.0451	0.172	CbGbCtD
Diltiazem—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.0451	0.172	CbGbCtD
Diltiazem—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0338	0.129	CbGbCtD
Diltiazem—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0325	0.124	CbGbCtD
Diltiazem—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0273	0.104	CbGbCtD
Diltiazem—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0227	0.0864	CbGbCtD
Diltiazem—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.022	0.0839	CbGbCtD
Diltiazem—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0207	0.079	CbGbCtD
Diltiazem—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0132	0.0503	CbGbCtD
Diltiazem—CACNG1—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN4—focal segmental glomerulosclerosis	0.00235	0.126	CbGpPWpGaD
Diltiazem—Gingival hyperplasia—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.0545	CcSEcCtD
Diltiazem—Pyelonephritis—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.0386	CcSEcCtD
Diltiazem—Stomach ache—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.0345	CcSEcCtD
Diltiazem—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.0304	CcSEcCtD
Diltiazem—CACNA1S—NCAM1 interactions—COL4A4—focal segmental glomerulosclerosis	0.00118	0.0631	CbGpPWpGaD
Diltiazem—CACNA1S—NCAM1 interactions—COL4A1—focal segmental glomerulosclerosis	0.00108	0.058	CbGpPWpGaD
Diltiazem—Gastric ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0253	CcSEcCtD
Diltiazem—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000924	0.0226	CcSEcCtD
Diltiazem—CACNA1S—NCAM1 interactions—COL4A3—focal segmental glomerulosclerosis	0.000915	0.049	CbGpPWpGaD
Diltiazem—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000855	0.0209	CcSEcCtD
Diltiazem—CACNA1C—NCAM1 interactions—COL4A4—focal segmental glomerulosclerosis	0.00084	0.045	CbGpPWpGaD
Diltiazem—CACNA1C—NCAM1 interactions—COL4A1—focal segmental glomerulosclerosis	0.000772	0.0414	CbGpPWpGaD
Diltiazem—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN4—focal segmental glomerulosclerosis	0.00077	0.0413	CbGpPWpGaD
Diltiazem—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.000712	0.0174	CcSEcCtD
Diltiazem—CACNA1S—NCAM signaling for neurite out-growth—COL4A4—focal segmental glomerulosclerosis	0.000692	0.0371	CbGpPWpGaD
Diltiazem—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.000668	0.0164	CcSEcCtD
Diltiazem—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000659	0.0161	CcSEcCtD
Diltiazem—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000659	0.0161	CcSEcCtD
Diltiazem—CACNA1C—NCAM1 interactions—COL4A3—focal segmental glomerulosclerosis	0.000652	0.035	CbGpPWpGaD
Diltiazem—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.000646	0.0158	CcSEcCtD
Diltiazem—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000646	0.0158	CcSEcCtD
Diltiazem—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.000642	0.0157	CcSEcCtD
Diltiazem—CACNA1S—NCAM signaling for neurite out-growth—COL4A1—focal segmental glomerulosclerosis	0.000636	0.0341	CbGpPWpGaD
Diltiazem—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.000611	0.0149	CcSEcCtD
Diltiazem—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.000589	0.0144	CcSEcCtD
Diltiazem—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000563	0.0138	CcSEcCtD
Diltiazem—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN4—focal segmental glomerulosclerosis	0.000549	0.0295	CbGpPWpGaD
Diltiazem—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.000542	0.0133	CcSEcCtD
Diltiazem—CACNA1S—NCAM signaling for neurite out-growth—COL4A3—focal segmental glomerulosclerosis	0.000538	0.0288	CbGpPWpGaD
Diltiazem—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.000536	0.0131	CcSEcCtD
Diltiazem—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.000523	0.0128	CcSEcCtD
Diltiazem—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00052	0.0127	CcSEcCtD
Diltiazem—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.0125	CcSEcCtD
Diltiazem—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.000496	0.0121	CcSEcCtD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—COL4A4—focal segmental glomerulosclerosis	0.000494	0.0265	CbGpPWpGaD
Diltiazem—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000486	0.0119	CcSEcCtD
Diltiazem—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.000473	0.0116	CcSEcCtD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—COL4A1—focal segmental glomerulosclerosis	0.000454	0.0243	CbGpPWpGaD
Diltiazem—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.000452	0.0111	CcSEcCtD
Diltiazem—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.000444	0.0109	CcSEcCtD
Diltiazem—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000435	0.0107	CcSEcCtD
Diltiazem—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.000428	0.0105	CcSEcCtD
Diltiazem—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.000412	0.0101	CcSEcCtD
Diltiazem—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.000397	0.00973	CcSEcCtD
Diltiazem—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.000392	0.00959	CcSEcCtD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—COL4A3—focal segmental glomerulosclerosis	0.000384	0.0206	CbGpPWpGaD
Diltiazem—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000379	0.00927	CcSEcCtD
Diltiazem—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000362	0.00886	CcSEcCtD
Diltiazem—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000361	0.00883	CcSEcCtD
Diltiazem—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.000347	0.00851	CcSEcCtD
Diltiazem—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000342	0.00838	CcSEcCtD
Diltiazem—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000339	0.00831	CcSEcCtD
Diltiazem—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000331	0.00809	CcSEcCtD
Diltiazem—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00033	0.00807	CcSEcCtD
Diltiazem—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000329	0.00805	CcSEcCtD
Diltiazem—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000329	0.00805	CcSEcCtD
Diltiazem—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000326	0.00798	CcSEcCtD
Diltiazem—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000326	0.00798	CcSEcCtD
Diltiazem—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000316	0.00774	CcSEcCtD
Diltiazem—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000315	0.0077	CcSEcCtD
Diltiazem—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000302	0.00739	CcSEcCtD
Diltiazem—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000301	0.00737	CcSEcCtD
Diltiazem—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000299	0.00731	CcSEcCtD
Diltiazem—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000297	0.00728	CcSEcCtD
Diltiazem—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000295	0.00722	CcSEcCtD
Diltiazem—CACNA1S—Alzheimers Disease—GNAQ—focal segmental glomerulosclerosis	0.000293	0.0157	CbGpPWpGaD
Diltiazem—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.0071	CcSEcCtD
Diltiazem—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000281	0.00687	CcSEcCtD
Diltiazem—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000279	0.00684	CcSEcCtD
Diltiazem—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000273	0.00669	CcSEcCtD
Diltiazem—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000271	0.00664	CcSEcCtD
Diltiazem—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000269	0.00658	CcSEcCtD
Diltiazem—CACNA1S—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.000268	0.0144	CbGpPWpGaD
Diltiazem—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000266	0.00651	CcSEcCtD
Diltiazem—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000262	0.00642	CcSEcCtD
Diltiazem—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000258	0.00632	CcSEcCtD
Diltiazem—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000257	0.0063	CcSEcCtD
Diltiazem—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000257	0.00628	CcSEcCtD
Diltiazem—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000255	0.00623	CcSEcCtD
Diltiazem—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000252	0.00617	CcSEcCtD
Diltiazem—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000247	0.00605	CcSEcCtD
Diltiazem—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000246	0.00601	CcSEcCtD
Diltiazem—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000243	0.00595	CcSEcCtD
Diltiazem—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000239	0.00586	CcSEcCtD
Diltiazem—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000236	0.00579	CcSEcCtD
Diltiazem—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000235	0.00576	CcSEcCtD
Diltiazem—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000235	0.00574	CcSEcCtD
Diltiazem—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000229	0.0056	CcSEcCtD
Diltiazem—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000223	0.00546	CcSEcCtD
Diltiazem—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000223	0.00546	CcSEcCtD
Diltiazem—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000223	0.00546	CcSEcCtD
Diltiazem—CACNA1S—Alzheimers Disease—LPL—focal segmental glomerulosclerosis	0.000221	0.0118	CbGpPWpGaD
Diltiazem—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00022	0.0054	CcSEcCtD
Diltiazem—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000218	0.00534	CcSEcCtD
Diltiazem—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000214	0.00524	CcSEcCtD
Diltiazem—CACNA1C—Regulation of insulin secretion—GNAQ—focal segmental glomerulosclerosis	0.000213	0.0114	CbGpPWpGaD
Diltiazem—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000213	0.0052	CcSEcCtD
Diltiazem—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00021	0.00513	CcSEcCtD
Diltiazem—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000209	0.00513	CcSEcCtD
Diltiazem—CACNA1C—Alzheimers Disease—GNAQ—focal segmental glomerulosclerosis	0.000209	0.0112	CbGpPWpGaD
Diltiazem—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000207	0.00506	CcSEcCtD
Diltiazem—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000204	0.00499	CcSEcCtD
Diltiazem—CACNA1S—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.000199	0.0106	CbGpPWpGaD
Diltiazem—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000195	0.00477	CcSEcCtD
Diltiazem—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000193	0.00474	CcSEcCtD
Diltiazem—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000192	0.0047	CcSEcCtD
Diltiazem—CACNA1S—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.000192	0.0103	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—MYH10—focal segmental glomerulosclerosis	0.000192	0.0103	CbGpPWpGaD
Diltiazem—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000191	0.00467	CcSEcCtD
Diltiazem—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00019	0.00465	CcSEcCtD
Diltiazem—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000188	0.00461	CcSEcCtD
Diltiazem—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000186	0.00455	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000185	0.00452	CcSEcCtD
Diltiazem—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000184	0.00451	CcSEcCtD
Diltiazem—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000183	0.00448	CcSEcCtD
Diltiazem—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000183	0.00448	CcSEcCtD
Diltiazem—CACNA1S—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.000182	0.00978	CbGpPWpGaD
Diltiazem—CACNA1S—Calcium Regulation in the Cardiac Cell—GNAQ—focal segmental glomerulosclerosis	0.000176	0.00946	CbGpPWpGaD
Diltiazem—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000176	0.00431	CcSEcCtD
Diltiazem—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00017	0.00416	CcSEcCtD
Diltiazem—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000169	0.00414	CcSEcCtD
Diltiazem—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000169	0.00414	CcSEcCtD
Diltiazem—CACNA1C—Integration of energy metabolism—GNAQ—focal segmental glomerulosclerosis	0.000168	0.009	CbGpPWpGaD
Diltiazem—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000158	0.00386	CcSEcCtD
Diltiazem—CACNA1C—Alzheimers Disease—LPL—focal segmental glomerulosclerosis	0.000157	0.00843	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.000154	0.00827	CbGpPWpGaD
Diltiazem—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000153	0.00376	CcSEcCtD
Diltiazem—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000151	0.0037	CcSEcCtD
Diltiazem—CACNA1S—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.000147	0.00788	CbGpPWpGaD
Diltiazem—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000146	0.00358	CcSEcCtD
Diltiazem—CACNA1S—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000142	0.0076	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.000142	0.00759	CbGpPWpGaD
Diltiazem—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000141	0.00346	CcSEcCtD
Diltiazem—CACNA1C—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.000137	0.00733	CbGpPWpGaD
Diltiazem—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000136	0.00333	CcSEcCtD
Diltiazem—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000135	0.0033	CcSEcCtD
Diltiazem—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000135	0.0033	CcSEcCtD
Diltiazem—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000134	0.00328	CcSEcCtD
Diltiazem—CACNA1S—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.00013	0.00698	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.00013	0.00698	CbGpPWpGaD
Diltiazem—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000127	0.00311	CcSEcCtD
Diltiazem—CACNA1C—Calcium Regulation in the Cardiac Cell—GNAQ—focal segmental glomerulosclerosis	0.000126	0.00675	CbGpPWpGaD
Diltiazem—CYP2C19—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000124	0.00663	CbGpPWpGaD
Diltiazem—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000114	0.0061	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.000113	0.00608	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00011	0.0059	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00011	0.0059	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000105	0.00563	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.000105	0.00562	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000101	0.00542	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	9.29e-05	0.00498	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	8.09e-05	0.00434	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—TRPC6—focal segmental glomerulosclerosis	8.09e-05	0.00434	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	7.85e-05	0.00421	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—MYH9—focal segmental glomerulosclerosis	7.49e-05	0.00401	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	7.22e-05	0.00387	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	6.39e-05	0.00342	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	6.25e-05	0.00335	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	5.77e-05	0.00309	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	5.35e-05	0.00287	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—LPL—focal segmental glomerulosclerosis	5.09e-05	0.00273	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—MMP2—focal segmental glomerulosclerosis	4.78e-05	0.00256	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	4.77e-05	0.00256	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	4.74e-05	0.00254	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	3.99e-05	0.00214	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—LPL—focal segmental glomerulosclerosis	3.63e-05	0.00195	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—MMP9—focal segmental glomerulosclerosis	3.59e-05	0.00193	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—MMP2—focal segmental glomerulosclerosis	3.41e-05	0.00183	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—MMP2—focal segmental glomerulosclerosis	3.41e-05	0.00183	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—MMP9—focal segmental glomerulosclerosis	2.56e-05	0.00137	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—MMP9—focal segmental glomerulosclerosis	2.56e-05	0.00137	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—MMP2—focal segmental glomerulosclerosis	2.43e-05	0.0013	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	2.41e-05	0.00129	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—LIPC—focal segmental glomerulosclerosis	2.37e-05	0.00127	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	2.18e-05	0.00117	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	2.11e-05	0.00113	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CTGF—focal segmental glomerulosclerosis	2.08e-05	0.00112	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.04e-05	0.00109	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.92e-05	0.00103	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—MMP9—focal segmental glomerulosclerosis	1.83e-05	0.00098	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.82e-05	0.000975	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.79e-05	0.000961	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.66e-05	0.000889	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.64e-05	0.000878	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.6e-05	0.000858	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.51e-05	0.000808	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.46e-05	0.000782	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	1.45e-05	0.000777	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—LPL—focal segmental glomerulosclerosis	1.44e-05	0.000774	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	1.28e-05	0.000684	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.24e-05	0.000666	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—AGT—focal segmental glomerulosclerosis	1.24e-05	0.000662	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.18e-05	0.00063	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.11e-05	0.000595	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	1.08e-05	0.000577	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.06e-05	0.00057	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	1.05e-05	0.000561	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.01e-05	0.000542	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	9.49e-06	0.000509	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—ALB—focal segmental glomerulosclerosis	9.48e-06	0.000508	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	9.22e-06	0.000494	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	9.07e-06	0.000486	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	8.84e-06	0.000474	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	8.65e-06	0.000464	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.5e-06	0.000455	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	8.16e-06	0.000437	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	8.1e-06	0.000434	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	7.99e-06	0.000428	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	7.9e-06	0.000424	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	7.56e-06	0.000405	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	7.45e-06	0.000399	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	7.38e-06	0.000396	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.36e-06	0.000394	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	7.28e-06	0.00039	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	7.13e-06	0.000382	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	6.96e-06	0.000373	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.76e-06	0.000362	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	6.64e-06	0.000356	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.57e-06	0.000352	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	6.56e-06	0.000351	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	6.5e-06	0.000348	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.41e-06	0.000344	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	6.39e-06	0.000343	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.04e-06	0.000324	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.99e-06	0.000321	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	5.8e-06	0.000311	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	5.54e-06	0.000297	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	5.47e-06	0.000293	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	4.94e-06	0.000265	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	4.87e-06	0.000261	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	4.82e-06	0.000259	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	4.74e-06	0.000254	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	4.54e-06	0.000244	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	4.51e-06	0.000242	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	4.29e-06	0.00023	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	4.23e-06	0.000227	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	4.2e-06	0.000225	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	4.13e-06	0.000221	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.95e-06	0.000212	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	3.89e-06	0.000208	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	3.85e-06	0.000207	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	3.63e-06	0.000195	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	3.24e-06	0.000174	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	3.17e-06	0.00017	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	2.98e-06	0.00016	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	2.97e-06	0.000159	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	2.96e-06	0.000159	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.54e-06	0.000136	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.95e-06	0.000105	CbGpPWpGaD
